IGC Pharma, Inc. - COM NEW (IGC)

Historical Holders from Q1 2014 to Q3 2025

Symbol
IGC on NYSE
Type / Class
Equity / COM NEW
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
5,439,804
Holdings value
$2,266,241
% of all portfolios
0%
Number of holders
34
Number of buys
17
Number of sells
-5
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 5,439,804 $2,266,241 +$1,001,142 $0.4169 34
2025 Q2 3,037,215 $929,392 +$57,233 $0.306 27
2025 Q1 2,858,700 $814,910 -$631 $0.285 23
2024 Q4 2,840,185 $954,327 +$6,302 $0.336 29
2024 Q3 2,802,614 $1,193,381 +$99,486 $0.4269 22
2024 Q2 2,559,014 $1,109,942 +$92,789 $0.4338 24
2024 Q1 2,357,049 $943,391 -$17,836 $0.4 25
2023 Q4 2,467,956 $691,288 -$128,787 $0.2801 25
2023 Q3 2,824,090 $1,013,374 +$60,622 $0.3593 27
2023 Q2 2,653,184 $827,470 -$16,523 $0.3116 22
2023 Q1 2,705,115 $917,600 -$79,599 $0.3395 22
2022 Q4 2,945,826 $937,255 -$47,900 $0.3181 23
2022 Q3 3,044,710 $1,309,000 -$115,201 $0.4292 18
2022 Q2 3,267,303 $1,729,000 -$1,067,336 $0.5295 22
2022 Q1 4,179,042 $3,965,474 -$1,935,631 $0.949 22
2021 Q4 6,219,909 $6,073,000 +$587,717 $0.9763 23
2021 Q3 5,334,857 $7,900,000 +$612,691 $1.48 29
2021 Q2 4,807,060 $7,893,000 +$553,068 $1.64 26
2021 Q1 4,450,764 $7,963,000 +$2,116,276 $1.79 25
2020 Q4 3,256,530 $5,077,000 +$1,886,338 $1.56 20
2020 Q3 2,101,295 $2,184,000 +$269,274 $1.04 20
2020 Q2 1,917,300 $1,147,000 +$239,193 $0.5993 16
2020 Q1 1,419,568 $693,000 -$52,354 $0.4892 12
2019 Q4 1,587,329 $999,000 +$77,226 $0.6298 17
2019 Q3 1,507,252 $1,463,000 -$183,930 $0.971 17
2019 Q2 1,538,933 $2,522,000 +$1,830,939 $1.64 23
2019 Q1 419,197 $871,000 +$594,961 $2.08 16
2018 Q4 309,175 $108,000 -$1,591,620 $0.3293 2
2018 Q3 472,561 $3,034,000 +$2,076,284 $6.45 19
2018 Q2 304,000 $150,000 -$41,945 $0.497 7
2018 Q1 383,188 $215,000 +$118,091 $0.5636 7
2017 Q4 163,799 $164,000 +$31,508 $1 6
2017 Q3 222,638 $78,000 -$21,168 $0.3607 6
2017 Q2 559,556 $222,000 +$128,766 $0.4022 8
2017 Q1 240,860 $104,000 -$505 $0.4699 6
2016 Q4 239,560 $68,000 +$49,480 $0.2858 6
2016 Q3 61,463 $29,000 +$26,000 $0.5 5
2016 Q2 6,650 $4,000 -$143,302 $0.6349 3
2016 Q1 281,791 $146,000 +$119,602 $0.5175 7
2015 Q4 50,613 $12,000 -$17,193 $0.2364 3
2015 Q3 118,766 $23,000 +$8,948 $0.1943 3
2015 Q2 63,129 $26,000 +$16,758 $0.4319 5
2015 Q1 22,885 $10,000 -$18,969 $0.4351 3
2014 Q4 53,367 $37,000 -$1,869 $0.7046 5
2014 Q3 51,552 $36,000 -$411,510 $0.7014 4
2014 Q2 325,254 $462,320 -$11,088 $1.42 5
2014 Q1 353,214 $276,000 -$5,617 $0.7781 4